Synonyms: BCD-145 | BCD145
Compound class:
Antibody
Comment: Nurulimab (BCD-145) is a human IgG1 anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) monoclonal antibody. It blocks the interaction between CTLA4 and its ligands CD80 and CD86, which establishes an inhibitory immune checkpoint. Blocking this checkpoint offers therapeutic potential as this mechanism stimulates the immune system to destroy cancer cells.
|
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
11141 | nurulimab |
Synonyms |
BCD-145 | BCD145 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 960 |
Other databases | |
GtoPdb PubChem SID | 485206113 |
Search PubMed clinical trials | nurulimab |
Search PubMed titles | nurulimab |
Search PubMed titles/abstracts | nurulimab |